Annum Chief Medical Officer Urges Evidence-Based Treatment in Opioid Crisis
"Scientifically, this is a settled matter."
Annum's Chief Medical Officer, Dr. Mark Willenbring, was interviewed by the Associated Press in the wake of conflicting comments by U.S. Department of Health and Human Services about including medicines as part of treatment for opioid addiction. Writes the Associated Press:
"A 2014 review of 31 studies found methadone and buprenorphine keep people in treatment and off illicit drugs.[...]
"Not informing patients about the effectiveness of treating addiction with medication is like a doctor not telling a cancer patient about chemotherapy, said Dr. Mark Willenbring, a former director of treatment research at the National Institute for Alcohol Abuse and Alcoholism. 'Scientifically, this is a settled matter.'"